Skip to main content
. 2020 Dec 1;8(4):719. doi: 10.3390/vaccines8040719

Figure 2.

Figure 2

Figure 2

Reactivity of tetanus-specific monoclonal antibodies (mAbs) with C. trachomatis serovar B (A) and C. caviae (B). Threshold binding was determined with respect to mAbs other than mAb26 and mAb51 and presented as a mean +2SD (light magenta solid/doted lines). All samples were assessed in triplicate and results presented as a mean ± S.E; * p < 0.05, *** p < 0.001 compared to the threshold binding.